Changes of diffusing capacity after neoadjuvant concurrent chemoradiotherapy: implication on postoperative pulmonary complications in non-small cell lung cancer patients
s. shin (seoul, Republic of Korea), Y. Choi (seoul, Republic of Korea), J. Jung (seoul, Republic of Korea), Y. Im (seoul, Republic of Korea), H. Park (seoul, Republic of Korea), J. Cho (seoul, Republic of Korea), H. Kim (seoul, Republic of Korea), J. Kim (seoul, Republic of Korea), J. Zo (seoul, Republic of Korea), Y. Shim (seoul, Republic of Korea), H. Lee (seoul, Republic of Korea), H. Park (seoul, Republic of Korea)
Source: International Congress 2018 – Lung cancer: personalised medicine
Session: Lung cancer: personalised medicine
Session type: Poster Discussion
Number: 2225
Disease area: Thoracic oncology
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
s. shin (seoul, Republic of Korea), Y. Choi (seoul, Republic of Korea), J. Jung (seoul, Republic of Korea), Y. Im (seoul, Republic of Korea), H. Park (seoul, Republic of Korea), J. Cho (seoul, Republic of Korea), H. Kim (seoul, Republic of Korea), J. Kim (seoul, Republic of Korea), J. Zo (seoul, Republic of Korea), Y. Shim (seoul, Republic of Korea), H. Lee (seoul, Republic of Korea), H. Park (seoul, Republic of Korea). Changes of diffusing capacity after neoadjuvant concurrent chemoradiotherapy: implication on postoperative pulmonary complications in non-small cell lung cancer patients. 2225
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you: